New hope for DVT patients: common arthritis drug may prevent lasting vein damage
NCT ID NCT07432529
First seen Feb 25, 2026 · Last updated May 20, 2026 · Updated 12 times
Summary
This study tests whether adding colchicine, an anti-inflammatory medicine, to standard blood thinners can reduce the risk of long-term vein damage (post-thrombotic syndrome) in people with a first-time deep vein clot in the leg. About 940 adults will receive either colchicine or a placebo for one year. The goal is to see if this combination improves vein recovery and quality of life without increasing side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS INSUFFICIENCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.